165 related articles for article (PubMed ID: 27116978)
1. Large-scale assessment of the gliomasphere model system.
Laks DR; Crisman TJ; Shih MY; Mottahedeh J; Gao F; Sperry J; Garrett MC; Yong WH; Cloughesy TF; Liau LM; Lai A; Coppola G; Kornblum HI
Neuro Oncol; 2016 Oct; 18(10):1367-78. PubMed ID: 27116978
[TBL] [Abstract][Full Text] [Related]
2. Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature.
Erhart F; Blauensteiner B; Zirkovits G; Printz D; Soukup K; Klingenbrunner S; Fischhuber K; Reitermaier R; Halfmann A; Lötsch D; Spiegl-Kreinecker S; Berger W; Visus C; Dohnal A
J Cell Mol Med; 2019 Jan; 23(1):281-292. PubMed ID: 30467961
[TBL] [Abstract][Full Text] [Related]
3. Gliomagenesis is orchestrated by the Oct3/4 regulatory network.
Ignatova TN; Chaitin HJ; Kukekov NV; Suslov ON; Dulatova GI; Hanafy KA; Vrionis FD
J Neurosurg Sci; 2024 Apr; 68(2):148-156. PubMed ID: 34342203
[TBL] [Abstract][Full Text] [Related]
4. Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival.
Ernst A; Hofmann S; Ahmadi R; Becker N; Korshunov A; Engel F; Hartmann C; Felsberg J; Sabel M; Peterziel H; Durchdewald M; Hess J; Barbus S; Campos B; Starzinski-Powitz A; Unterberg A; Reifenberger G; Lichter P; Herold-Mende C; Radlwimmer B
Clin Cancer Res; 2009 Nov; 15(21):6541-50. PubMed ID: 19861460
[TBL] [Abstract][Full Text] [Related]
5. Pathway-based approach reveals differential sensitivity to E2F1 inhibition in glioblastoma.
Alvarado AG; Tessema K; Muthukrishnan SD; Sober M; Kawaguchi R; Laks DR; Bhaduri A; Swarup V; Nathanson DA; Geschwind DH; Goldman SA; Kornblum HI
Cancer Res Commun; 2022 Sep; 2(9):1049-1060. PubMed ID: 36213002
[TBL] [Abstract][Full Text] [Related]
6. Statistical pattern analysis of gene expression profiles for glioblastoma tissues and cell lines.
Hess KR; Fuller GN; Rhee CH; Zhang W
Int J Mol Med; 2001 Aug; 8(2):183-8. PubMed ID: 11445872
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling reveals Ki-67 associated proliferation signature in human glioblastoma.
Jin Q; Zhang W; Qiu XG; Yan W; You G; Liu YW; Jiang T; Wang L
Chin Med J (Engl); 2011 Sep; 124(17):2584-8. PubMed ID: 22040407
[TBL] [Abstract][Full Text] [Related]
8. Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene.
Lin B; Lee H; Yoon JG; Madan A; Wayner E; Tonning S; Hothi P; Schroeder B; Ulasov I; Foltz G; Hood L; Cobbs C
Oncotarget; 2015 Mar; 6(7):5369-81. PubMed ID: 25749033
[TBL] [Abstract][Full Text] [Related]
9. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
10. A combined gene signature of hypoxia and notch pathway in human glioblastoma and its prognostic relevance.
Irshad K; Mohapatra SK; Srivastava C; Garg H; Mishra S; Dikshit B; Sarkar C; Gupta D; Chandra PS; Chattopadhyay P; Sinha S; Chosdol K
PLoS One; 2015; 10(3):e0118201. PubMed ID: 25734817
[TBL] [Abstract][Full Text] [Related]
11. EGFRvIII/integrin β3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis.
Liu Z; Han L; Dong Y; Tan Y; Li Y; Zhao M; Xie H; Ju H; Wang H; Zhao Y; Zheng Q; Wang Q; Su J; Fang C; Fu S; Jiang T; Liu J; Li X; Kang C; Ren H
Oncotarget; 2016 Jan; 7(4):4680-94. PubMed ID: 26717039
[TBL] [Abstract][Full Text] [Related]
12. Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis.
Shirahata M; Iwao-Koizumi K; Saito S; Ueno N; Oda M; Hashimoto N; Takahashi JA; Kato K
Clin Cancer Res; 2007 Dec; 13(24):7341-56. PubMed ID: 18094416
[TBL] [Abstract][Full Text] [Related]
13. The comparison genomics analysis with glioblastoma multiforme (GBM) cells under 3D and 2D cell culture conditions.
Ma L; Zhang B; Zhou C; Li Y; Li B; Yu M; Luo Y; Gao L; Zhang D; Xue Q; Qiu Q; Lin B; Zou J; Yang H
Colloids Surf B Biointerfaces; 2018 Dec; 172():665-673. PubMed ID: 30243220
[TBL] [Abstract][Full Text] [Related]
14. Expression analysis of all protease genes reveals cathepsin K to be overexpressed in glioblastoma.
Verbovšek U; Motaln H; Rotter A; Atai NA; Gruden K; Van Noorden CJ; Lah TT
PLoS One; 2014; 9(10):e111819. PubMed ID: 25356585
[TBL] [Abstract][Full Text] [Related]
15. LncRNA and mRNA interaction study based on transcriptome profiles reveals potential core genes in the pathogenesis of human glioblastoma multiforme.
Yan Y; Zhang L; Jiang Y; Xu T; Mei Q; Wang H; Qin R; Zou Y; Hu G; Chen J; Lu Y
J Cancer Res Clin Oncol; 2015 May; 141(5):827-38. PubMed ID: 25378224
[TBL] [Abstract][Full Text] [Related]
16. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B
Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157
[TBL] [Abstract][Full Text] [Related]
17. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
[TBL] [Abstract][Full Text] [Related]
18. Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.
Yong WH; Shabihkhani M; Telesca D; Yang S; Tso JL; Menjivar JC; Wei B; Lucey GM; Mareninov S; Chen Z; Liau LM; Lai A; Nelson SF; Cloughesy TF; Tso CL
PLoS One; 2015; 10(10):e0141334. PubMed ID: 26506620
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme.
Liang Y; Diehn M; Watson N; Bollen AW; Aldape KD; Nicholas MK; Lamborn KR; Berger MS; Botstein D; Brown PO; Israel MA
Proc Natl Acad Sci U S A; 2005 Apr; 102(16):5814-9. PubMed ID: 15827123
[TBL] [Abstract][Full Text] [Related]
20. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR
Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
